Farzaneh Barati | Biotechnology | Research Excellence Award

Dr. Farzaneh Barati | Biotechnology | Research Excellence Award

Alzahra University | Iran

Dr. Farzaneh Barati is a microbial biotechnology researcher whose work integrates molecular biology, enzyme engineering, nanobiotechnology, microbial genetics, and computational bioprocess design to advance innovative and sustainable biotechnological applications. With five Scopus-indexed publications, 103 citations, and an h-index of 4, she has built a growing research footprint centered on microbial metabolic optimization, green nanotechnology, and in silico–supported enzyme engineering. Her contributions include notable advancements in polyhydroxy butyrate (PHB) biosynthesis through the cloning and overexpression of the phbC gene in Ralstonia eutropha, offering valuable insights for enhancing biodegradable biopolymer production. She has also contributed significantly to environmentally friendly nanomaterial synthesis by optimizing copper oxide nanoparticle production using plant-derived extracts, applying design of experiments (DOE) and response surface methodology (RSM) to improve nanoparticle yield and functionality. Dr. Farzaneh Barati’s influential systematic reviews on bioactive peptide generation and computational strategies for enzyme immobilization demonstrate her ability to combine experimental biotechnology with advanced computational analysis, providing frameworks for more efficient enzyme stabilization and catalytic improvement. Her research further includes the isolation and molecular characterization of a collagenase-producing microorganism from slaughterhouse-contaminated soil, resulting in a publicly deposited GenBank sequence (OR555920) and subsequent studies exploring its enzyme–nanoparticle interactions. Through her multidisciplinary contributions spanning microbial biotechnology, sustainable nanotechnology, and data-driven enzyme engineering, she continues to advance scientific understanding and strengthen the development of next-generation bioprocesses with industrial, environmental, and biomedical relevance.

Profiles: Scopus | Google Scholar | ORCID | ResearchGate

Featured Publications

1. Barati, M., Javanmardi, F., Mousavi Jazayeri, S. M. H., Jabbari, M., Rahmani, J., et al. (2020). Techniques, perspectives, and challenges of bioactive peptide generation: A comprehensive systematic review. Comprehensive Reviews in Food Science and Food Safety, 19(4), 1488–1520.

2. Barati, F., Asgarani, E., Gharavi, S., & Soudi, M. R. (2020). Considerable increase in Poly (3-hydroxybutyrate) production via phbC gene overexpression in Ralstonia eutropha PTCC 1615. BioImpacts (BI), 11(1), 53.

3. Barati, F., Hosseini, F., Vafaee, R., Sabouri, Z., Ghadam, P., Arab, S. S., Shadfar, N., et al. (2024). In silico approaches to investigate enzyme immobilization: A comprehensive systematic review. Physical Chemistry Chemical Physics, 26(7), 5744–5761.

4. Barati, F., Hosseini, F., Ghadam, P., & Arab, S. S. (2024). Optimizing CuO nanoparticle synthesis via walnut green husk extract utilizing response surface methodology. Journal of Molecular Structure, 1316, 139077.

5. Barati, F., Hosseini, F., Moghadam, F. H., & Dezfouli, S. A. (2021). Face mask as a tool to prevent the Coronavirus disease 2019: The importance and challenges. International Journal of Health and Life Sciences, 7(1), e109729.

Eduardo Vignoto Fernandes | Medicine and Health Sciences | Research Excellence Award

Prof. Dr. Eduardo Vignoto Fernandes | Medicine and Health Sciences | Research Excellence Award

Federal University of Jataí | Brazil

Prof. Dr. Eduardo Vignoto Fernandes, is a distinguished researcher in immunometabolism, human physiology, and applied health sciences, recognized for his multidisciplinary contributions integrating experimental pathology, human anatomy, and exercise science. With 28 Scopus-indexed publications, 119 citations, and an h-index of 5, his research advances understanding of metabolic, genetic, and physiological adaptations in healthy individuals and those with clinical or lifestyle-related conditions, including people living with HIV/AIDS. Fernandes has produced influential studies covering immunometabolism responses, exercise physiology, body composition, sports nutrition, metabolic syndrome, cancer immunopathology, and antiretroviral therapy effectiveness. His scientific output includes peer-reviewed articles, systematic reviews, and collaborative investigations published in respected journals such as Metabolites, Geriatrics, Sports, Current HIV Research, Molecular Biology Reports, and Discover Public Health. Fernandes leads and collaborates on research projects exploring exercise prescription, photo biomodulation, osteopathic interventions, muscle damage biomarkers, and functional health indicators such as handgrip strength. His expertise also extends to educational research on human anatomy, including remote versus in-person instruction and academic performance in health-science students. Through public health outreach initiatives, he contributes to community wellness by developing structured exercise programs and participating in One Health–aligned interdisciplinary actions. Supported by competitive funding from major Brazilian agencies, he conducts R&D focused on immunometabolism health, functional performance, and applied health interventions. His growing citation base, broad research themes, and sustained collaborations underscore his scientific relevance and expanding impact across exercise science, pathology, and applied health research.

Profiles: Scopus | Google Scholar | ORCID | ResearchGate

Featured Publications

1. De Rossi, T., Lozovoy, M. A. B., da Silva, R. V., Fernandes, E. V., Geraldino, T. H., & others. (2011). Interações entre Candida albicans e hospedeiro. Semina: Ciências Biológicas e da Saúde, 32(1), 15–28.

2. Weber, M. G., Dias, S. S., de Angelis, T. R., Fernandes, E. V., Bernardes, A. G., & others. (2021). The use of BCAA to decrease delayed-onset muscle soreness after a single bout of exercise: A systematic review and meta-analysis. Amino Acids, 53(11), 1663–1678.

3. Romanin, P., Palermo, R. L., Cavalini, J. F., Favaro, L. S., De Paula-Petroli, S. B., Fernandes, E. V., & others. (2019). Multidrug- and extensively drug-resistant Acinetobacter baumannii in a tertiary hospital from Brazil: The importance of carbapenemase encoding genes and related resistance mechanisms. Microbial Drug Resistance, 25(9), 1365–1373.

4. Khan, S. A., Venancio, E. J., Ono, M. A., Fernandes, E. V., Hirooka, E. Y., Shimizu, C. F., & others. (2019). Effects of subcutaneous ochratoxin-A exposure on immune system of broiler chicks. Toxins, 11(5), 264.

5. Vitorino, R. W. S., Fornaziero, C. C., & Fernandes, E. V. (2020). Evaluation of performance and perception of learning in teaching human anatomy: Traditional method vs constructivist method. International Journal of Morphology, 38(1), 74–77.

Mehrdad Hashemi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Prof. Mehrdad Hashemi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Tehran Medical Sciences, Islamic Azad University | Iran

Professor Mehrdad Hashemi is a renowned scholar in Molecular and Medical Genetics whose pioneering research has made transformative contributions to predictive, preventive, and personalized medicine. His scientific work focuses on the discovery of diagnostic and therapeutic biomarkers particularly non-coding RNAs (lncRNAs and miRNAs) with profound implications for early disease detection, molecular targeting, and precision therapy. Prof. Mehrdad Hashemi has authored 372 peer-reviewed publications indexed in Scopus, accumulating over 6,826 citations from 6,242 documents, and achieving a remarkable h-index of 41. His research portfolio includes 299 ISI-indexed papers, 342 Scopus-indexed papers, and 258 PubMed articles, encompassing 119 Q1 and 82 Q2 journals. He has led or completed 14 major research projects, contributed to 95 industrial and academic collaborations, and maintained 110 international research partnerships with leading institutions across the USA, UK, Canada, China, Germany, Australia, and beyond. His scholarly output also includes 3 internationally published books and 1 patent. Ranked among the World’s Top 1% and 2% Scientists in both ESI (2024) and Stanford (2024–2025) global rankings, Prof. Mehrdad Hashemi’s groundbreaking studies on exosomes, nanomedicine, gene regulation, and cancer therapeutics have advanced global understanding of disease mechanisms and innovative treatment modalities. He also contributes extensively as an editorial board member, peer reviewer, and thought leader in the field of molecular diagnostics and translational genetics.

Profiles: Scopus | Google Scholar | ORCID | Staff Page

Featured Publications

  • Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., … & Hashemi, M. (2022). Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. Journal of Hematology & Oncology, 15(1), 83. https://doi.org/10.1186/s13045-022-01296-0

  • Bolhassani, A., Javanzad, S., Saleh, T., Hashemi, M., Aghasadeghi, M. R., … & Sadat, S. M. (2014). Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases. Human Vaccines & Immunotherapeutics, 10(2), 321–332. https://doi.org/10.4161/hv.26796

  • Entezari, M., Hashemi, D., Taheriazam, A., Zabolian, A., Mohammadi, S., … & Hashemi, M. (2022). AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation. Biomedicine & Pharmacotherapy, 146, 112563. https://doi.org/10.1016/j.biopha.2021.112563

  • Hashemi, M., Moosavi, M. S., Abed, H. M., Dehghani, M., Aalipour, M., Heydari, E. A., … & Mirzaei, S. (2022). Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. Pharmacological Research, 184, 106418. https://doi.org/10.1016/j.phrs.2022.106418

  • Sadrkhanloo, M., Entezari, M., Orouei, S., Ghollasi, M., Rezaei, S., Hejazi, E. S., … & Hashemi, M. (2022). STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response. Pharmacological Research, 182, 106311. https://doi.org/10.1016/j.phrs.2022.106311

Zhiwei Zhong | Medicine and Health Sciences | Best Researcher Award

Dr. Zhiwei Zhong | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Nanchang University | China

Dr. Zhiwei Zhong’s research focuses on molecular oncology, nanomedicine, and biomarker discovery in complex diseases such as pancreatic cancer, hepatocellular carcinoma, thyroid eye disease, and venous thromboembolism. His studies integrate bioinformatics, molecular biology, and nanotechnology to uncover therapeutic targets and diagnostic biomarkers. Zhong has contributed to several high-impact publications in PLOS One, Cancer Cell International, Oncology Reports, Digestive Diseases and Sciences, and SN Applied Sciences. His notable works include identifying key extracellular proteins (EGFR, CD44, and CXCL8) as potential biomarkers in thyroid eye disease, elucidating the regulatory role of lncRNA FTX in suppressing NAFLD progression to hepatocellular carcinoma via Kupffer cell polarization, and exploring nanoparticle-based drug delivery systems for targeted thrombolysis and cancer therapy. He has also investigated tumor suppressor mechanisms involving KLF9 and CHD1L in pancreatic cancer, providing insights into tumor proliferation, invasion, and survival pathways. His research contributions advance the understanding of molecular pathogenesis, precision diagnostics, and targeted nanotherapeutic strategies in human diseases.

Profile: ORCID

Featured Publications

  1. He, S., Nie, H., Yin, X., & Zhong, Z. (2025, April). Identification of key extracellular proteins as the potential biomarkers in thyroid eye disease. PLOS ONE, 20(4), e0322415. https://doi.org/10.1371/journal.pone.0322415

Hanchen Zhou | Medicine and Health Sciences | Best Researcher Award

Mr. Hanchen Zhou | Medicine and Health Sciences | Best Researcher Award

Beijing Stomatological Hospital Affiliated to Capital Medical University | China

Hanchen Zhou, a graduate student at Beijing Stomatological Hospital, Capital Medical University, is an emerging researcher specializing in Oral and Maxillofacial-Head and Neck Oncology, with a primary focus on oral squamous cell carcinoma. He has already distinguished himself by publishing four SCI-indexed research papers that contribute valuable insights into the molecular mechanisms, clinical behavior, and potential treatment strategies for this aggressive malignancy. These publications, cited internationally, reflect his growing influence in oncology research and his ability to translate clinical challenges into innovative scientific solutions. Zhou is actively engaged in funded research projects, including the Innovation Foundation and the Clinical Research Incubation Project of Beijing Stomatological Hospital, demonstrating his capacity to design and execute impactful investigations. A member of the Chinese Stomatological Association, he actively participates in academic collaboration and professional development, strengthening his role within the wider scientific community. Despite being in the early stages of his career, Zhou has already showcased a strong commitment to advancing cancer research, particularly in bridging experimental findings with clinical applications. His work not only enhances the understanding of oral squamous cell carcinoma but also paves the way for improved diagnostic and therapeutic approaches. By integrating scientific rigor with a clear vision for innovation, he exemplifies the qualities of a promising researcher poised for long-term impact.

Profile: Scopus | ResearchGate

Featured Publications

  • Yu, H., Li, B., Huang, Y., & Zhang, X. (2025). Prognosis of second primary oral squamous cell carcinoma after hematologic malignancy: A retrospective cohort analysis. Frontiers in Oncology, 15, Article 1667226. https://doi.org/10.3389/fonc.2025.1667226

  • Zhou, H., Luo, C., Xu, Q., & Wang, C. (2025). Machine learning approach to predict surgical site infection in head and neck squamous cell carcinoma patients after free flap reconstruction. Journal of Cranio-Maxillofacial Surgery. Advance online publication. https://doi.org/10.1016/j.jcms.2025.09.010

  • Cheng, A., Wei, K., Xu, Q., & Wang, C. (2025). The comparison of the prognostic value of different inflammation-related indicators in patients with oral squamous cell carcinoma. Frontiers in Genetics, 16, Article 1652603. https://doi.org/10.3389/fgene.2025.1652603

  • Li, B., Zhao, Z., Huang, Y., & Zhou, H. (2025). The application of adjuvant radiotherapy in pN1 OSCC patients without adverse pathologic features. Oral Diseases, 31(1), e15336. https://doi.org/10.1111/odi.15336

Xuan Zhang | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr. Xuan Zhang | Medicine and Health Sciences | Best Researcher Award

Hong Kong Baptist University | Hong Kong

Dr. Xuan Zhang is a highly respected Lecturer II at the School of Chinese Medicine, Hong Kong Baptist University. As a registered Chinese Medicine Practitioner in both Mainland China and Hong Kong, she has cultivated a strong academic and clinical foundation rooted in traditional Chinese medicine principles. Since joining HKBU in 2016, she has significantly contributed to teaching, research, and international academic collaborations. Her leadership in evidence-based research, combined with her deep understanding of the Huangdi Neijing and classical theories such as the Five Circuits and Six Qi, positions her as a pioneer in integrating tradition with modern scientific approaches. Dr. Zhang has led or participated in more than 15 externally funded projects and published over 100 peer-reviewed articles, with a strong record of first- and corresponding-author contributions.

Professional Profile

ORCID

Scopus

Education

Dr. Zhang earned her Ph.D. in Chinese Medicine from the prestigious Beijing University of Chinese Medicine. Her doctoral training provided a rich combination of theoretical studies, classical text interpretation, and hands-on clinical applications. The academic environment fostered her early interest in integrating traditional Chinese medical theories with scientific methodologies. Her educational path laid the groundwork for her to pursue rigorous research in both the theoretical foundations and practical applications of Chinese medicine, particularly in the fields of epidemiology, gastrointestinal diseases, and methodological development.

Experience

With close to a decade of academic and clinical teaching experience, Dr. Zhang has taken on numerous roles that extend beyond the classroom. Since joining HKBU in 2016, she has secured seven research grants as Principal Investigator and served as co-investigator in multiple national-level projects funded by organizations such as the National Natural Science Foundation of China and the Chinese Medicine Development Fund (HKSAR). Her expertise has led to contributions in reporting guideline development, multicentre clinical trials, and telemedicine studies. She also serves on editorial boards for international journals such as Scientific Reports, BMC Medical Research Methodology, and the Journal of Traditional Chinese Medical Sciences, underscoring her standing in the academic community.

Research Interests

Dr. Zhang’s core research areas include: (1) theoretical and clinical research based on the Huangdi Neijing, with a focus on the “Five Circuits and Six Qi” (Wu Yun Liu Qi); (2) development of evidence-based Chinese medicine practices and methodological reporting standards; (3) clinical studies on gastrointestinal diseases such as IBS and ulcerative colitis; and (4) epidemiological research in infectious diseases within the framework of Chinese medicine. She has championed multidisciplinary and cross-regional collaborations that explore the integration of data science with ancient medical systems. Her ongoing work also addresses the modernization and standardization of traditional practices to ensure global acceptance and scientific validation.

Awards and Recognition

Dr. Zhang has received numerous awards for her outstanding research and contributions to Chinese medicine. She was named among China’s CNKI Highly Cited Scholars (Top 1%) and received the “Top Cited Article” award in the Journal of Evidence-Based Medicine. She was also honored as one of the “100 Outstanding Reviewers” of the China Journal of Traditional Chinese Medicine and Pharmacy and recognized as the “1st Qiu Zhen Scholars of Chinese Medicine.” Additionally, she earned the “Top Articles in Outstanding S&T Journals of China” award twice and the “Third Prize of Science and Technology Award” from the China Association of Chinese Medicine. These accolades reflect her significant impact on both theoretical and applied Chinese medicine research.

Publications

  1. Title: A Protocol for Developing, Disseminating, and Implementing a Core Outcome Set for Clinical Trials of Integrative Chinese and Western Medicine for Ulcerative Colitis
    Journal: Journal of Integrative Medicine
    Published on: 31 Jul 2025

  2. Title: Butyrate-producing commensal bacteria mediates the efficacy of herbal medicine JCM-16021 on abdominal pain in diarrhea-predominant irritable bowel syndrome: a randomized clinical trial
    Journal: Phytomedicine
    Published on: Sep 2025

  3. Title: Outcomes reporting in clinical trials of Chinese herbal medicine on ulcerative colitis: A systematic review
    Journal: Journal of Evidence-Based Medicine
    Published on: 28 Oct 2024

  4. Title: Suboptimal reporting of randomized controlled trials on non-pharmacological therapies in Chinese medicine
    Journal: Frontiers in Medicine
    Published on: 17 Jun 2024

  5. Title: Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine formulas interventions
    Journal: Frontiers of Medicine
    Published on: 17 May 2024

  6. Title: STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): Extending the CONSORT Statement
    Journal: Journal of Evidence-Based Medicine
    Published on: 14 Mar 2023

  7. Title: Reporting assessment of multicenter clinical trial protocols: a cross-sectional study
    Journal: Journal of Evidence-Based Medicine
    Published on: 03 Mar 2023

Conclusion

Dr. Xuan Zhang is a distinguished researcher, educator, and clinical scholar whose work reflects a deep integration of traditional Chinese medicine principles with contemporary clinical and scientific practices. Her extensive publication record, grant leadership, and editorial responsibilities demonstrate her strong research acumen and commitment to globalizing Chinese medicine. With high-impact contributions, international collaborations, and multiple recognitions for academic excellence, Dr. Zhang is a highly deserving candidate for the Best Researcher Award. Her work continues to shape the future of evidence-based Chinese medicine and methodological innovation.

Ishita Biswas | Biology | Best Researcher Award

Dr. Ishita Biswas | Biology | Best Researcher Award

Assistant Professor | S.B.S. Government College, Hili | India

Dr. Ishita Biswas is an esteemed Assistant Professor in Botany at S. B. S. Government College, Hili, West Bengal, India. With a rich academic background in microbiology and plant sciences, she has made remarkable contributions to microbial research and plant biochemistry. Her dedication to advancing scientific knowledge is evident through her extensive research, numerous accolades, and commitment to mentoring young scholars.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

  • 🌟 Academic Excellence: Dr. Biswas has consistently excelled academically, earning top ranks throughout her educational journey, including a silver medal for securing the second position in her Master of Science in Botany.
  • 📊 Research Contributions: She has published 17 full-length research papers in reputed journals, including Elsevier and MDPI, showcasing a diverse range of research interests from plant biochemistry to microbiology.
  • 🏅 Awards and Recognition: Her achievements include multiple “Best Presenter” and “Outstanding Paper” awards at international conferences, reflecting her ability to effectively communicate research findings.
  • 🧬 GenBank Submissions: Submission of seven gene sequences to NCBI highlights her contributions to genetic research, which is a valuable addition to the scientific community.
  • 👩‍🏫 Professional Involvement: Active participation in academic committees, student welfare initiatives, and administrative roles demonstrates her dedication to institutional development.
  • 🌐 Interdisciplinary Approach: Her research integrates microbiology, biochemistry, and plant physiology, reflecting a multidisciplinary perspective.
  • 📈 Competitive Edge: Qualifying for prestigious exams like UGC JRF-NET, GATE, and SET further underscores her academic rigor and research potential.

Education 🎓

Dr. Biswas’s academic journey began at WBBSE, where she completed her secondary education with distinction. She earned her B.Sc. and M.Sc. in Botany from the University of North Bengal, securing first-class honors. Her quest for knowledge led her to pursue a B.Ed. and ultimately a Ph.D. in Microbiology from Raiganj University in 2024. Additionally, she qualified for prestigious examinations such as UGC JRF-NET, NET-LS, SET, and GATE, showcasing her academic excellence.

Experience 💼

Currently serving as an Assistant Professor at S. B. S. Government College, Hili, Dr. Biswas plays an active role in various academic and administrative committees. She has served as the Convener of the Students’ Welfare & Disciplinary Sub-Committee and Joint Convener of the Routine Sub-Committee and Women Grievance & Redressal Cell. Additionally, she contributes to the External Examination, Sports, Internal Complaint, UGC, and Website Sub-Committees.

Research Interests On Biology 🔬

Dr. Biswas’s research interests lie in plant biochemistry, plant physiology, and microbiology. Her work focuses on microbial interactions, enzyme characterization, and exploring natural methods for environmental remediation. She is particularly passionate about studying plant-microbe interactions and harnessing microbial potential for sustainable agriculture and bioremediation.

Awards 🏆

  • Silver Medal from the Honorable Governor for securing First Class Second Position in M.Sc. Botany, University of North Bengal (2013).
  • “Best Presenter Award” at the 7th Annual International Conference Biospectrum 2023, organized by the University of Engineering and Management, Kolkata, in collaboration with Universiti Sains Malaysia (2023).
  • “Outstanding Paper Award” at the 6th Regional Science & Technology Congress (Region 2) (2023-24).
  • “Best Presenter Award” at the 8th Annual International Conference Biospectrum 2024, organized by the University of Engineering and Management, Kolkata, in collaboration with the University of Iasi, Romania (2024).

Publications 📖

  • Title: Valorization of vermicompost with bacterial fermented chicken feather hydrolysate for the yield improvement of tomato plant: A novel organic combination
    Authors: I Biswas, D Mitra, A Senapati, D Mitra, S Chattaraj, M Ali, G Basak
    Year: 2021
    Citations: 25

  • Title: Bioactive compounds as a potential inhibitor of colorectal cancer; an insilico study of Gallic acid and Pyrogallol
    Authors: D Mitra, A Dey, I Biswas, PK Das Mohapatra
    Year: 2021
    Citations: 23

  • Title: Recent advancement in metabiotics: a consortium with bioactive molecules after fermentation by probiotic bacteria with multidisciplinary application potential and future prospects
    Authors: I Biswas, PKD Mohapatra
    Year: 2023
    Citations: 21

  • Title: Contributions of protein microenvironment in tannase industrial applicability: An in-silico comparative study of pathogenic and non-pathogenic bacterial tannase
    Authors: I Biswas, D Mitra, AK Bandyopadhyay, PKD Mohapatra
    Year: 2020
    Citations: 17

  • Title: Structural and catalytic advancement of fungal tannase: A proteomic contribution in industrial applicability
    Authors: I Biswas, D Mitra, PKD Mohapatra
    Year: 2022
    Citations: 14

  • Title: Concomitant yield optimization of tannase and gallic acid by Bacillus licheniformis KBR6 through submerged fermentation: An industrial approach
    Authors: PKD Mohapatra, I Biswas, KC Mondal, BR Pati
    Year: 2020
    Citations: 12

  • Title: Application of egg shell with fortified vermicompost in Capsicum cultivation: a strategy in waste management
    Authors: I Biswas, D Mitra, D Mitra, S Chattaraj, A Senapati, A Chakraborty
    Year: 2022
    Citations: 10

  • Title: Paraburkholderia tropica PKI7 and Kosakonia arachidis PKI8: Two newly reported tannase producing bacteria isolated from forest soil and study of their tannase producing potential
    Authors: I Biswas, PKDAS Mohapatra
    Year: 2023
    Citations: 6

  • Title: Preparation of metabiotic curd and optimization of tannase and gallic acid production by probiotic Lactiplantibacillus plantarum PKI15
    Authors: I Biswas, JP Soren, PKD Mohapatra
    Year: 2024
    Citations: 5

  • Title: Insilico sequence-structure based analysis of bacterial chromate reductase to unravel enzymatic specificity towards chromium pollution
    Authors: I Biswas, D Mitra
    Year: 2024
    Citations: 4

Conclusion 📊

Dr. Ishita Biswas has made significant strides in the field of botany and microbiology. Her dedication to research and education, coupled with numerous accolades and a strong publication record, highlights her passion for advancing scientific knowledge. She continues to inspire future generations through her teaching and research, leaving an indelible mark in her field.

Pingyu Zhang | Biochemistry | Best Researcher Award

Prof. Pingyu Zhang | Biochemistry | Best Researcher Award

Shenzhen University | China

Pingyu Zhang is a distinguished professor and deputy director of the Department of Chemistry at Shenzhen University. She obtained her Ph.D. in 2015 under the mentorship of Professor Hui Chao at Sun Yat-sen University. Following her doctoral studies, she joined the University of Warwick as a Newton Fellow in Professor Peter J. Sadler’s group from 2015 to 2017. Since 2017, she has been a faculty member at Shenzhen University, where she has made significant contributions to the field of chemistry. In recognition of her outstanding research, she was honored as a Young Chang Jiang Scholar by the Ministry of Education in 2023.

Professional profile👤

ORCID

Google Scholar

Scopus

Strengths for the Awards✨

  1. Outstanding Research Contributions

    • Professor Zhang has made significant advancements in the field of metal complex drugs for tumor-driven therapy, particularly in light- and sound-sensitive anti-tumor treatments.
    • Her pioneering work in sonodynamic therapy using metal complexes has opened new avenues for deep-tumor treatment, demonstrating high scientific impact.
  2. Academic Excellence & Recognitions

    • Recognized as a Young Chang Jiang Scholar (2023) by the Ministry of Education, a prestigious honor highlighting her research excellence.
    • Recipient of the Second-Class Natural Science Award of Shenzhen (2023, first contributor) and the Dalton Division Horizon Prize (2022) from the Royal Society of Chemistry.
  3. Research Productivity & Innovation

    • Published over 80 research papers in reputable journals, reflecting her consistent contributions to the scientific community.
    • Holds 18 Chinese invention patents, indicating her strong emphasis on translational research and innovation.
  4. International Experience & Collaborations

    • Gained global exposure through her postdoctoral research as a Newton Fellow at the University of Warwick (2015-2017) under the mentorship of Professor Peter J. Sadler.
    • Established a strong research presence both nationally and internationally, positioning her as a leading scientist in her field.

Education 🎓

Pingyu Zhang completed her Ph.D. in Chemistry at Sun Yat-sen University in 2015 under the guidance of Professor Hui Chao. Her academic journey equipped her with a strong foundation in metal complex chemistry, which later became a cornerstone of her research career.

Experience 💼

Following her Ph.D., Professor Zhang worked as a Newton Fellow at the University of Warwick from 2015 to 2017, collaborating with Professor Peter J. Sadler on groundbreaking research in metal-based therapeutics. In 2017, she joined Shenzhen University as a faculty member, where she currently serves as a distinguished professor and deputy director of the Department of Chemistry. Her leadership and dedication have significantly advanced the department’s research initiatives.

Research Interests On Biochemistry 🌍

Professor Zhang’s research focuses on the fundamental study of metal complex drugs for tumor-driven therapy. She has pioneered the development of light- and sound-sensitive anti-tumor drugs, creating innovative therapeutic strategies. Notably, she was the first to identify the potential application of metal complexes in sonodynamic therapy, a promising approach for treating deep-seated tumors. Her work aims to enhance cancer treatment efficacy while minimizing side effects.

Awards 🏆

  • Young Chang Jiang Scholar, Ministry of Education (2023)
  • Second-Class Natural Science Award of Shenzhen (First Contributor, 2023)
  • Dalton Division Horizon Prize, Royal Society of Chemistry (2022)

Publications 📚

Professor Zhang has published over 80 research papers in prestigious journals and holds 18 Chinese invention patents. Below are some of her notable publications:

  1. Highly stable single Pt atomic sites anchored on aniline-stacked graphene for hydrogen evolution reaction

    • Authors: S Ye, F Luo, Q Zhang, P Zhang, T Xu, Q Wang, D He, L Guo, Y Zhang, …
    • Year: 2019
    • Citations: 474
  2. Highly charged ruthenium (II) polypyridyl complexes as lysosome‐localized photosensitizers for two‐photon photodynamic therapy

    • Authors: H Huang, B Yu, P Zhang, J Huang, Y Chen, G Gasser, L Ji, H Chao
    • Year: 2015
    • Citations: 445
  3. Targeted photoredox catalysis in cancer cells

    • Authors: H Huang, S Banerjee, K Qiu, P Zhang, O Blacque, T Malcomson, …
    • Year: 2019
    • Citations: 398
  4. Advances in the design of organometallic anticancer complexes

    • Authors: P Zhang, PJ Sadler
    • Year: 2017
    • Citations: 392
  5. New designs for phototherapeutic transition metal complexes

    • Authors: C Imberti, P Zhang, H Huang, PJ Sadler
    • Year: 2020
    • Citations: 377
  6. Ruthenium (II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents

    • Authors: J Liu, Y Chen, G Li, P Zhang, C Jin, L Zeng, L Ji, H Chao
    • Year: 2015
    • Citations: 278
  7. Targeting nucleus DNA with a cyclometalated dipyridophenazineruthenium (II) complex

    • Authors: H Huang, P Zhang, B Yu, Y Chen, J Wang, L Ji, H Chao
    • Year: 2014
    • Citations: 230
  8. Redox‐active metal complexes for anticancer therapy

    • Authors: P Zhang, PJ Sadler
    • Year: 2017
    • Citations: 213
  9. Boosting the alkaline hydrogen evolution of Ru nanoclusters anchored on B/N–doped graphene by accelerating water dissociation

    • Authors: S Ye, F Luo, T Xu, P Zhang, H Shi, S Qin, J Wu, C He, X Ouyang, Q Zhang, …
    • Year: 2020
    • Citations: 174
  10. Noncovalent ruthenium (II) complexes–single-walled carbon nanotube composites for bimodal photothermal and photodynamic therapy with near-infrared irradiation

  • Authors: P Zhang, H Huang, J Huang, H Chen, J Wang, K Qiu, D Zhao, L Ji, …
  • Year: 2015
  • Citations: 167

Conclusion 🎯

Pingyu Zhang is a leading researcher in the field of metal-based tumor therapy, with significant contributions to the development of innovative anti-cancer strategies. Through her pioneering work in sonodynamic and photodynamic therapy, she continues to push the boundaries of cancer treatment. Her numerous accolades, high-impact publications, and patents underscore her influence in the scientific community, making her a key figure in advancing metal complex drug research.

Kevin Pak | Medicine | Best Researcher Award

Dr. Kevin Pak | Medicine | Best Researcher Award

Transplant Hepatology Fellow | UCLA | United States

Dr. Kevin C. Pak, M.D., is a distinguished transplant hepatologist affiliated with the Pflieger Liver Institute at the David Geffen School of Medicine at UCLA. With a strong background in internal medicine, gastroenterology, and hepatology, Dr. Pak has dedicated his career to advancing liver disease treatment and transplantation. His contributions to academic research and clinical practice have earned him recognition in the medical community.

Profile👤

Google Scholar

Scopus

Strengths for the Awards✨

Exceptional Research Contributions: Dr. Pak has an extensive portfolio of peer-reviewed publications in prestigious journals, covering a range of topics in gastroenterology, hepatology, and military medicine. His research on hepatitis B, hepatocellular carcinoma, liver transplantation, and inflammatory bowel disease is particularly noteworthy.

Clinical and Academic Leadership: As an Assistant Professor at USUHS and a former Chief Fellow in a gastroenterology fellowship, Dr. Pak has demonstrated strong mentorship and leadership in academic medicine. His contributions to teaching and training future physicians further emphasize his dedication to research and education.

Recognized Excellence: Multiple honors and awards, including the AASLD Emerging Liver Scholar Award (2019) and Resident Researcher of the Year, highlight his significant impact in the field. His invited presentations and poster sessions at national and international conferences further validate his research reputation.

Interdisciplinary and Military Medicine Contributions: His unique background in military medicine and research contributions in military healthcare settings (e.g., inflammatory bowel disease in active-duty personnel) provide a broader impact beyond civilian medicine.

Education 🎓

Dr. Pak began his academic journey at the United States Military Academy (USMA) in West Point, New York, earning a B.S. in Life Sciences. He then pursued his medical degree at the F. Edward Hébert School of Medicine at the Uniformed Services University of the Health Sciences (USUHS) in Bethesda, Maryland. His postgraduate training includes an Internal Medicine Residency at Walter Reed National Military Medical Center, followed by a Gastroenterology & Hepatology Fellowship at Naval Medical Center San Diego. He further specialized in Transplant Hepatology through a fellowship at the Pflieger Liver Institute at UCLA.

Experience 💼

Dr. Pak has held several academic positions, including Assistant Professor of Medicine and Teaching Fellow at USUHS. He is actively involved in medical education, mentoring students and residents. His clinical expertise spans hepatology, transplant medicine, and gastroenterology, making him a key contributor to the field. Additionally, Dr. Pak has served in the military, where he provided medical services in critical care settings.

Research Interests On Medicine🔬

Dr. Pak’s research focuses on liver disease, hepatocellular carcinoma, chronic hepatitis B, and liver transplantation. He is particularly interested in optimizing treatment strategies for liver disease and investigating emerging therapies. His work contributes to advancements in hepatology, improving patient outcomes and clinical practices.

Awards 🏆

Dr. Pak has received numerous accolades throughout his career. He was honored with the Resident Researcher of the Year Award and the AASLD Emerging Liver Scholar Award. His excellence in teaching earned him the James J. Leonard Award for Excellence in Teaching. In his military service, he received commendations such as the Navy/Marine Corps Commendation Medal and the Joint Service Commendation Medal.

Publications 📚

Dr. Pak has authored multiple peer-reviewed publications in prestigious journals. His notable works include:

  • Systematic review of safety of selective androgen receptor modulators in healthy adults: implications for recreational users

    • Authors: JD Vignali, KC Pak, HR Beverley, JP DeLuca, JW Downs, AT Kress, …
    • Publication Year: 2023
    • Citations: 38
  • Wilson’s disease and iron overload: pathophysiology and therapeutic implications

    • Authors: K Pak, S Ordway, B Sadowski, M Canevari, D Torres
    • Publication Year: 2021
    • Citations: 23
  • Helicobacter pylori Treatment Regimen Selection and Eradication Rates Across Department of Defense Patients for Fiscal Years 2016-2018

    • Authors: ZC Junga, A Mertz, K Pak, M Singla
    • Publication Year: 2023
    • Citations: 9
  • The Patterns and Associated Cost of Serologic Testing for Helicobacter pylori in the U.S. Military Health System

    • Authors: K Pak, Z Junga, A Mertz, M Singla
    • Publication Year: 2020
    • Citations: 6
  • State of the art: Test all for anti-hepatitis D virus and reflex to hepatitis D virus RNA polymerase chain reaction quantification

    • Authors: E Umukoro, JJ Alukal, K Pak, J Gutierrez
    • Publication Year: 2023
    • Citations: 5
  • Occult HBV infection: a case series at a military treatment facility

    • Authors: K Pak, S Ordway, D Torres
    • Publication Year: 2020
    • Citations: 4
  • An acute presentation of chronic gastric volvulus

    • Authors: K Pak, Z Junga, P Young
    • Publication Year: 2020
    • Citations: 4
  • Decades of cough: Delayed recognition of atypical cystic fibrosis in an adult patient

    • Authors: A Chandel, K Pak, S Dooley, K Salazar
    • Publication Year: 2020
    • Citations: 3
  • A small blemish: isotretinoin-induced microscopic colitis

    • Authors: LR Dukate, K Pak, W O’Connell, Z Junga
    • Publication Year: 2022
    • Citations: 2
  • A Case of Whipple’s Disease With Concomitant Esophageal Candidiasis

    • Authors: R Choi, A Pazevic, K Pak, M Skaret, A Bachmann, R Wilkerson
    • Publication Year: 2024
    • Citations: 1

Conclusion 🔍

Dr. Kevin C. Pak, M.D., is a dedicated physician, educator, and researcher in hepatology and gastroenterology. His commitment to advancing liver disease treatment, coupled with his academic and clinical expertise, makes him a key figure in the field. Through his research, mentorship, and clinical practice, Dr. Pak continues to contribute significantly to medical science and patient care.

Dharmalingam Kirubakaran | Biology | Best Researcher Award

Dr. Dharmalingam Kirubakaran | Biology | Best Researcher Award

Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University | India

Dr. Dharmalingam Kirubakaran is a dedicated researcher with over five years of experience in biomaterials, phytochemistry, nanotechnology, and their biological applications. He has a strong background in medicinal plant surveys and biodiversity conservation, actively contributing to innovative advancements in these fields. Currently serving as an Assistant Professor in the Department of Pharmacology at Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, he continues to explore groundbreaking research in nanoscience and biotechnology.

Profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Diverse Research Expertise – With specialization in biomaterials, phytochemistry, nanotechnology, and their biomedical applications, Dr. Kirubakaran has a strong interdisciplinary research background.

Significant Publication Record – He has 21 publications in high-impact journals (Wiley, Elsevier, Springer, ACS, etc.), demonstrating a strong research contribution.

Innovative Research Focus – His work on green synthesis of nanoparticles and their applications in medicine (antibacterial, anticancer, and wound healing) is highly relevant to modern scientific advancements.

Academic and Professional Standing – Currently serving as an Assistant Professor at Saveetha Medical College, he contributes to both research and education.

Research Impact & Collaboration – His contributions extend to toxicological studies, biodiversity conservation, and environmental remediation, making his work impactful in multiple domains.

Education 🎓

  • Ph.D. in Botany (2022 – 2024), Periyar University, Tamil Nadu, India
    Thesis: Green Synthesis of Nanoparticles, characterization from Strobilanthes cordifolia J.R.I. Wood and its Biomedical Applications.
  • M.Phil in Botany (2020 – 2021), Periyar University, Tamil Nadu, India
    Dissertation: Phytochemical analysis and evaluation of pharmacological applications from Strobilanthes cordifolia J.R.I. Wood leaves extract.
  • M.Sc. in Botany (2017 – 2019), Periyar University, Tamil Nadu, India
    Dissertation: Synthesis and characterization of TiO2 nanoparticles from Pleurotus sajor-caju edible mushroom extract and its biological activities.
  • B.Sc. in Botany (2014 – 2017), Government Arts College, Tamil Nadu, India.

Experience 💼

  • Assistant Professor – Department of Pharmacology, Saveetha Medical College and Hospital, SIMATS, Chennai.
  • Expertise in phytochemistry, nanotechnology, in-vitro experimental studies, environmental research, and toxicology.
  • Proficient in advanced techniques such as GC-MS, LC-MS, molecular docking, and synthesis of nanocomposite materials.

Research Interests On Biology🔍

  • Green synthesis of nanoparticles and their biomedical applications.
  • Phytochemical screening and pharmacological analysis of medicinal plants.
  • Toxicological studies and environmental sustainability.
  • Development of eco-friendly nanomaterials for antimicrobial and anticancer applications.

Awards & Recognitions 🏆

  • Recognized for contributions to nanoscience and phytochemistry.
  • Reviewer for reputed journals such as Plant Physiology and Biochemistry and Open Nano (Elsevier).
  • Active member of scientific societies related to biotechnology and nanotechnology.

Publications 📚

  1. Bio-fabrication of Zinc oxide nanoparticles using Strobilanthes cordifolia

    • Year: 2024
    • Authors: Kirubakaran, D.; Selvam, K.; Subramanian Shivakumar, M.; Rajkumar, M.; Kannan, S.; Navina, B.
    • Citations: Not provided
  2. Bioefficacy of Zinc oxide nanoparticle synthesis and their Biological, Environmental applications from Eranthemum roseum

    • Year: 2024
    • Authors: Adhavan, R.; Selvam, K.; Prakash, P.; Manimegalai, P.; Kirubakaran, D.; Shivakumar, M.S.
    • Citations: Not provided
  3. Biogenic synthesis of copper nanoparticle using Impatiens chinensis L

    • Year: 2024
    • Authors: Kirubakaran, D.; Selvam, K.; Dhaneeshram, M.; Shivakumar, M.S.; Rajkumar, M.; Shanmugarathinam, A.
    • Citations: Not provided
  4. Biosynthesis and biological activities of magnesium hydroxide nanoparticles using Tinospora cordifolia leaf extract

    • Year: 2024
    • Authors: Rajkumar, M.; Presley, S.I.D.; Menaa, F.; Elbehairi, S.E.I.; Alfaifi, M.Y.; Shati, A.A.; Albalawi, A.E.; Althobaiti, N.A.; Kirubakaran, D.; Govindaraj, P. et al.
    • Citations: Not provided
  5. Green synthesis of gelatin-loaded magnesium hydroxide nanocomposite biomaterial using Coleus amboinicus leaf extract

    • Year: 2024
    • Authors: Rajkumar, M.; Kirubakaran, D.; Selvam, K.; Prathap, N.; Thangaraj, R.; Vimala, K.; Kannan, S.
    • Citations: Not provided
  6. Green synthesis of zinc oxide (ZnO) nanoparticles using aqueous leaf extract of Hardwickia binata

    • Year: 2024
    • Authors: Manimegalai, P.; Selvam, K.; Loganathan, S.; Kirubakaran, D.; Shivakumar, M.S.; Govindasamy, M.; Rajaji, U.; Bahajjaj, A.A.A.
    • Citations: Not provided
  7. Larvicidal, bactericidal, antioxidant, hypoglycemic effects and anti-proliferative activity of phyto-synthesized Ag-ZnO nanocomposites using Eranthemum roseum

    • Year: 2024
    • Authors: Adhavan, R.; Selvam, K.; Prakash, P.; Kirubakaran, D.; Shivakumar, M.S.
    • Citations: Not provided
  8. Nanomaterials for improving health of agricultural crops and forest trees

    • Year: 2024
    • Authors: Sethuraman, V.; Kumar, P.S.; Kirubakaran, D.; Shivakumar, M.S.
    • Citations: Not provided
  9. Revolutionary composites of silver and zinc oxide nanoparticles from Hardwickia binata

    • Year: 2024
    • Authors: Manimegalai, P.; Selvam, K.; Kirubakaran, D.; Subaramanian Shivakumar, M.; Nandhini, S.
    • Citations: Not provided
  10. Salvia coccinea Buc’hoz ex Etl. Leaf extract mediated synthesis of zinc oxide nanoparticles

  • Year: 2024
  • Authors: Kirubakaran, D.; Selvam, K.; Bagyalakshmi, G.; Manimegalai, P.; Adhavan, R.; Shivakumar, M.S.
  • Citations: Not provided

For a full list of publications, visit Google Scholar and ResearchGate.

Conclusion 🔖

Dr. Dharmalingam Kirubakaran is a passionate researcher and academician committed to bridging nanotechnology and phytochemistry for sustainable biomedical applications. His pioneering contributions to the synthesis of eco-friendly nanoparticles and their therapeutic potential are shaping the future of biomedicine. Through his dedication to teaching and research, he continues to inspire the next generation of scientists.